» Articles » PMID: 23327453

Willingness and Acceptability of Cervical Cancer Screening Among HIV Positive Nigerian Women

Overview
Publisher Biomed Central
Specialty Public Health
Date 2013 Jan 19
PMID 23327453
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The proven benefit of integrating cervical cancer screening programme into HIV care has led to its adoption as a standard of care. However this is not operational in most HIV clinics in Nigeria. Of the various reasons given for non-implementation, none is backed by scientific evidence. This study was conducted to assess the willingness and acceptability of cervical cancer screening among HIV positive Nigerian women.

Methods: A cross sectional study of HIV positive women attending a large HIV treatment centre in Lagos, Nigeria. Respondents were identified using stratified sampling method. A pretested questionnaire was used to obtain information by trained research assistants. Obtained information were coded and managed using SPSS for windows version 19. Multivariate logistic regression model was used to determine independent predictor for acceptance of cervical cancer screening.

Results: Of the 1517 respondents that returned completed questionnaires, 853 (56.2%) were aware of cervical cancer. Though previous cervical cancer screening was low at 9.4%, 79.8% (1210) accepted to take the test. Cost of the test (35.2%) and religious denial (14.0%) were the most common reasons given for refusal to take the test. After controlling for confounding variables in a multivariate logistic regression model, having a tertiary education (OR = 1.4; 95% CI: 1.03-1.84), no living child (OR: 1.5; 95% CI: 1.1-2.0), recent HIV diagnosis (OR: 1.5; 95% CI: 1.1-2.0) and being aware of cervical cancer (OR: 1.5; 95% CI: 1.2-2.0) retained independent association with acceptance to screen for cervical cancer.

Conclusions: The study shows that HIV positive women in our environment are willing to screen for cervical cancer and that the integration of reproductive health service into existing HIV programmes will strengthen rather than disrupt the services.

Citing Articles

Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey.

Asgedom Y, Hailegebireal A, Woldegeorgis B, Koyira M, Seifu B, Fente B PLoS One. 2024; 19(12):e0315438.

PMID: 39693312 PMC: 11654981. DOI: 10.1371/journal.pone.0315438.


To study the knowledge, attitude, and practice about Pap smear among healthcare professionals.

Latika , Suri R, Dahiya P J Educ Health Promot. 2024; 13:367.

PMID: 39679018 PMC: 11639484. DOI: 10.4103/jehp.jehp_244_24.


Determinants of cervical cancer screening intention among reproductive age women in Ethiopia: A systematic review and meta-analysis.

Lahole B, Woldamlak M, Kussia W PLoS One. 2024; 19(10):e0312449.

PMID: 39480772 PMC: 11527304. DOI: 10.1371/journal.pone.0312449.


Cervical cancer screening adoption behaviours among Nigerian women in academics: using a health belief model.

Iluno A, Oshiname F, Adekunle A, Dansou J BMC Womens Health. 2024; 24(1):534.

PMID: 39334054 PMC: 11429519. DOI: 10.1186/s12905-024-03380-w.


Scoping review protocol on the perception and attitude of women on methods for collecting cervicovaginal samples for human papillomavirus testing in sub-Saharan Africa.

Andrew-Bassey U, Oke D, Okunlola M, Morhason-Bello I BMJ Open. 2024; 14(6):e085408.

PMID: 38910004 PMC: 11328614. DOI: 10.1136/bmjopen-2024-085408.


References
1.
Parham G, Mwanahamuntu M, Sahasrabuddhe V, Westfall A, King K, Chibwesha C . Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness. HIV Ther. 2014; 4(6):703-722. PMC: 4237284. DOI: 10.2217/hiv.10.52. View

2.
Okonofua F . HPV vaccine and prevention of cervical cancer in Africa. Afr J Reprod Health. 2010; 11(2):7-12. View

3.
Batra P, Kuhn L, Denny L . Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. S Afr Med J. 2010; 100(1):39-44. View

4.
Chama C, Nggada H, Gashau W . Cervical dysplasia in HIV infected women in Maiduguri, Nigeria. J Obstet Gynaecol. 2005; 25(3):286-8. DOI: 10.1080/01443610500107601. View

5.
Leyden W, Manos M, Geiger A, Weinmann S, Mouchawar J, Bischoff K . Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005; 97(9):675-83. DOI: 10.1093/jnci/dji115. View